Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 46
Filter
1.
Eur Rev Med Pharmacol Sci ; 23(18): 8084-8086, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31599434

ABSTRACT

We present a woman with a three-year history of severe chronic urticaria and recurrent vulvo-vaginal Candidiasis in the setting of seasonal allergic rhinitis. Her past medical history was significant only for Bell's palsy in her childhood. Her review of systems was otherwise negative (specifically: no history of diarrhea, weight loss, malabsorption, anemia, nor eczema). Extensive testing revealed seasonal sensitivities to outdoor allergens and celiac disease. Repeating the evaluation six months after initiating a wheat-free diet, her vulvo-vaginal symptoms resolved.


Subject(s)
Candidiasis, Vulvovaginal/immunology , Celiac Disease/immunology , Chronic Urticaria/immunology , Rhinitis, Allergic, Seasonal/immunology , Ambrosia , Candidiasis, Vulvovaginal/complications , Celiac Disease/complications , Celiac Disease/diagnosis , Celiac Disease/diet therapy , Chronic Disease , Chronic Urticaria/complications , Diet, Gluten-Free , Duodenum/pathology , Female , Fissure in Ano/etiology , GTP-Binding Proteins/immunology , Gliadin/immunology , Humans , Immunoglobulin A/immunology , Intradermal Tests , Middle Aged , Poaceae , Protein Glutamine gamma Glutamyltransferase 2 , Rhinitis, Allergic, Seasonal/complications , Transglutaminases/immunology , Trees
2.
Eur Rev Med Pharmacol Sci ; 19(3): 392-5, 2015.
Article in English | MEDLINE | ID: mdl-25720708

ABSTRACT

BACKGROUND: A patient with psoriasis is presented who was treated with sublingual immunotherapy for airborne allergens for allergic rhinitis. Allergic rhinitis and psoriasis have entirely different cytokine profiles and result from different aberrations of the immune response. Furthermore, T-cell activation in the two diseases uses different presentation systems, psoriasis being a CD8 cytotoxic cell response requiring presentation through the Major Histocompatibility Complex I, while allergic rhinitis and its treatment with sublingual immunotherapy depend on CD4 T-helper cells and presentation by the Major Histocompatibility Complex II. The rapid and impressive improvement of the psoriatic lesions in the presented patient may, along with evidence of subsiding Th1 activity, give rise to the hypothesis that tolerogenic-to-allergen changes induced by sublingual immunotherapy may induce cross-tolerance and the selective emergence of cytotoxic T cell clones with lessened psoriasis-producing activity.


Subject(s)
Allergens , Psoriasis/therapy , Rhinitis, Allergic/therapy , Sublingual Immunotherapy/methods , Allergens/immunology , Child, Preschool , Female , Humans , Psoriasis/diagnosis , Psoriasis/immunology , Rhinitis, Allergic/diagnosis , Rhinitis, Allergic/immunology , Treatment Outcome
3.
Eur Rev Med Pharmacol Sci ; 15(10): 1117-21, 2011 Oct.
Article in English | MEDLINE | ID: mdl-22165671

ABSTRACT

BACKGROUND: Inflammation is a cardinal feature of migraines. A number of observations point to the possibility that an allergic component of a type I (IgE-mediated) nature may be involved in at least some migraineurs. Not only are migraines frequent among patients with allergic rhinitis but quite frequently the same medical approaches are beneficial in both diseases: anti-inflammatories, adrenergic tone modifiers, immune suppressants. The effect that immunotherapy for allergic rhinitis has upon migraines is studied. METHODS: Patients were recruited who suffered from typical migraines but were not treated with regular migraine controllers (beta blockers, antiepileptics, tricyclics, etc.). They underwent allergen-specific, sublingual immunotherapy with physician-formulated, individually-prepared airborne allergen extracts. Response to treatment was assessed with serum C-reactive protein level changes and symptom scores. Serum C-reactive protein (CRP), an acute phase reactant, was chosen as a marker because its usefulness has already been assessed in interictal migraine activity. RESULTS: Interictal serum CRP levels decline was observed in the course of sublingual immunotherapy. Concurrent improvement in symptom scores for both rhinitis and migraines was also observed. CONCLUSIONS: In patients with allergic rhinitis, migraine development and course may have a significant allergic component. Assessment of migraineurs for the possibility of coexisting allergic rhinitis is justified. Treatment of allergic rhinitis by immune response modifiers, such as immunotherapy, may have a place in the management of migraines for these patients.


Subject(s)
Desensitization, Immunologic , Migraine Disorders/therapy , Administration, Sublingual , Adolescent , Adult , C-Reactive Protein/analysis , Humans , Middle Aged , Migraine Disorders/blood , Prospective Studies , Quality of Life , Young Adult
4.
Eur Rev Med Pharmacol Sci ; 14(9): 785-8, 2010 Sep.
Article in English | MEDLINE | ID: mdl-21061838

ABSTRACT

OBJECTIVES: Successful treatment of severe, refractory Pemphigus vulgaris (PV) is reported. METHODS: Reduced intensity, non-myeloablative conditioning was employed, followed by allogeneic hematopoietic stem cell transplantation (HSCT) from a fully matched sibling. RESULTS: Treatment of refractory PV with myeloablation and subsequent allogenic HSCT has been previously reported, and sustained remission with this approach has been achieved. Toxicity, however, related to condition regimens remains high. CONCLUSION: Since no cytotoxic chemotherapy was used, it is hereby hypothesized that clinical improvement may result from regulatory action from the donor's marrow: a "graft modifying the disease" effect, which may prove useful in the management of autoimmune diseases.


Subject(s)
Hematopoietic Stem Cell Transplantation , Pemphigus/surgery , Transplantation Conditioning , Adult , Alemtuzumab , Antibodies, Monoclonal/administration & dosage , Antibodies, Monoclonal, Humanized , Antibodies, Neoplasm/administration & dosage , Female , Humans , Pemphigus/immunology , Pemphigus/pathology , Severity of Illness Index , Transplantation Conditioning/methods , Transplantation, Homologous , Treatment Outcome , Whole-Body Irradiation
5.
Bioresour Technol ; 99(8): 3174-81, 2008 May.
Article in English | MEDLINE | ID: mdl-17651967

ABSTRACT

Sunflower is a traditional crop which can be used for the production of bioenergy and liquid biofuels. A study of the pyrolytic behaviour of sunflower residues at temperatures from 300 to 600 degrees C has been carried out. The experiments were performed in a captive sample reactor under atmospheric pressure and helium as sweeping gas. The yields of the derived pyrolysis products were determined in relation to temperature, with constant sweeping gas flow of 50 cm3 min(-1) and heating rate of 40 degrees Cs(-1). The maximum gas yield of around 53 wt.% was obtained at 500 degrees C, whereas maximum oil yield of about 21 wt.% was obtained at 400 degrees C. A simple first order kinetic model has been applied for the devolatilization of biomass. Kinetic constants have been estimated: E=78.15 kJ mol(-1); k(0)=1.03 x 10(3)s(-1).


Subject(s)
Crops, Agricultural/metabolism , Gasoline , Helianthus/metabolism , Seeds/metabolism , Bioreactors , Energy Metabolism , Equipment Design , Greece , Helianthus/growth & development , Kinetics , Temperature
6.
7.
Ann Allergy Asthma Immunol ; 87(1 Suppl 1): 47-55, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11476476

ABSTRACT

OBJECTIVE: The primary objective of this review is to discuss systemic allergic reactions and risk factors associated with the injection of allergen vaccines. DATA SOURCES: A review of the literature on anaphylactic reaction, adverse effects, and fatalities associated with allergen immunotherapy (IT) was conducted. STUDY SELECTION: The expert opinion of the author was used to select relevant data. RESULTS: Systemic allergic reactions associated with the injection of allergen vaccines usually begin within 20 minutes. However, on occasion, they begin 20 to 30 minutes or longer after an injection. Such reactions can also occur after allergen skin testing. Most reactions associated with skin testing and allergen IT are mild and readily respond to appropriate treatment. However, severe and even fatal reactions have been reported with both skin testing and IT. CONCLUSIONS: Risk factors for skin testing and allergen IT include: 1) patients, particularly asthmatic patients, suffering with seasonal exacerbation of their symptoms; 2) patients who demonstrate exquisite sensitivity to particular allergen(s); 3) patients on beta-blockers; 4) patients with asthma, especially if their asthma is unstable; 5) patients in whom rush IT is used; and 6) patients in whom high doses of potent standardized allergen vaccines are used. It is essential that strict attention be paid to the risk factors for systemic reactions, and that techniques and management be initiated both before and after skin testing or IT to minimize these risks. Done properly, the risk of skin testing and IT is minimal.


Subject(s)
Allergens/therapeutic use , Immunotherapy/adverse effects , Humans , Immunotherapy/methods , Immunotherapy/mortality
8.
Am J Respir Crit Care Med ; 164(1): 72-6, 2001 Jul 01.
Article in English | MEDLINE | ID: mdl-11435241

ABSTRACT

UNLABELLED: This study evaluated the prevalence of upper respiratory symptoms (URS) among patients with symptomatic gastroesophageal reflux disease (GERD). Seventy-four subjects with heartburn completed a URS questionnaire before dual-probe, 24-h esophageal pH monitoring. The URS questionnaire was also completed by 74 normal volunteers without previous or current symptoms of GERD. Esophageal pH monitoring results were classified as normal, distal, or proximal and distal gastroesophageal reflux using standardized criteria. Mean URS scores (+/- SD) were 8.31 +/- 3.98 in the 52 subjects with GERD and 4.57 +/- 3.57 in the 22 subjects with negative pH probe studies, p = 0.02. Subjects with negative pH probe studies and normal volunteers scored similarly on the URS questionnaire. Reflux episodes/24 h correlated with URS scores, r = 0.47, p = 0.0001. Seventy-five percent of subjects with upper reflux, 68% of subjects with lower reflux, 36% of subjects with normal esophageal pH studies, and 9% of normal volunteers reported laryngeal symptoms for at least 5 d/mo. Sixty-nine percent of subjects with upper reflux, 50% of subjects with lower reflux, 31% of subjects with normal pH studies, and 14% of normal volunteers reported nasal symptoms for at least 5 d/mo. URS are frequent among subjects with GERD. KEYWORDS: rhinitis; upper airway; gastroesophageal reflux


Subject(s)
Gastroesophageal Reflux/complications , Rhinitis/complications , Adult , Aged , Aged, 80 and over , Female , Florida/epidemiology , Gastroesophageal Reflux/diagnosis , Gastroesophageal Reflux/physiopathology , Humans , Male , Middle Aged , Prevalence , Rhinitis/epidemiology , Rhinitis/physiopathology , Surveys and Questionnaires
9.
Arzneimittelforschung ; 50(6): 526-9, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10918944

ABSTRACT

Four sets of angiotensin II (AngII) analogues with position 5 modifications, two agonist series with either Asp or Sar in position 1 and L-Phe in position 8, and two antagonist series with again Asp or Sar in position 1 and Leu in position 8 were synthesized. Modifications in positions 5 were introduced successively: Ile, Nle, Met, S-ethyl Cys, S-n-propyl-Cys, S-n-butyl Cys, S-t-butyl Cys and S-benzyl Cys in all four series. The study was undertaken in order to investigate the 5-position residue of AngII by replacing the hydrophobic side-chain by another containing an electrophilic moiety. The analogues were synthesised by solid phase synthesis using the Boc/Bzl or Fmoc/But strategy. All analogues were evaluated by their binding properties to the AT1 receptor on bovine adrenocortical membranes (bAT1). The results indicate that AngII analogues bind, irrespective of their agonistic or antagonistic nature or of their position 1 modification, in a similar manner and that position 5 modifications without beta-branching behave in an additive manner towards their affinity.


Subject(s)
Angiotensin II/analogs & derivatives , Angiotensin II/pharmacology , Adrenal Cortex/drug effects , Adrenal Cortex/metabolism , Angiotensin I/metabolism , Angiotensin II/chemical synthesis , Animals , Cattle , Chromatography, Gel , In Vitro Techniques , Membranes/drug effects , Membranes/metabolism , Rabbits , Receptors, Angiotensin/drug effects , Receptors, Angiotensin/metabolism , Structure-Activity Relationship
10.
Allergy Asthma Proc ; 21(3): 159-66, 2000.
Article in English | MEDLINE | ID: mdl-10892518

ABSTRACT

Allergen immunotherapy (AIT) is the administration of increasing doses of an allergen vaccine to an allergic subject in order to reach a dose effective to improve symptoms associated with subsequent exposure to the causative allergen. This form of therapy is effective in the treatment of allergic rhinitis/conjunctivitis, allergic reactions to stinging insects, and allergic asthma. It is the only therapeutic modality that can affect the natural course of allergic diseases, and may prevent the development of asthma in patients with allergic rhinitis. AIT is indicated for patients with demonstrated specific IgE antibodies against clinically relevant allergens. The mixture of allergens to be utilized is based on the patient's history and skin and laboratory tests. The major risk of AIT is anaphylaxis. Such therapy is continued for three to five years, but the decision to discontinue it should be individualized. Interpretation of the history, physical findings, and skin and laboratory tests, the prescription and administration of allergen immunotherapy, its integration into the patient's treatment plan, and the decision to discontinue it require qualifying experience provided by specialist training in allergy and immunology.


Subject(s)
Desensitization, Immunologic , Hypersensitivity, Immediate/therapy , World Health Organization , Desensitization, Immunologic/adverse effects , Humans
12.
Allergy ; 54(7): 651-61, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10442520

ABSTRACT

Gastroesophageal reflux disease (GERD) occurs in up to one-third of the adult US population. Most affected individuals are either unaware of their condition or do not seek medical help, relying on nonprescription acid suppressants and antacids for relief. GERD, a common disorder of infancy, old age, and pregnancy, is particularly prevalent in patients with asthma. A causal relationship between the two diseases has been postulated by many investigators. The physiologic changes of asthma exacerbations and the actions of some of the medications used to treat asthma both aggravate GERD. The adverse effect of GERD on asthma and the pathophysiology of this relationship are still under debate. Some studies showed no objective improvement by spirometry of asthmatics treated for GERD, but recognized improvement in asthma symptoms and decreased use of asthma medication. Other studies, supporting GERD induction of asthma, have been performed to test two hypotheses: that asthma is exacerbated by endotracheal aspiration of gastric contents or by a reflex response to stimulation of esophageal receptors. Clinical experience has shown that early diagnosis and treatment of GERD often leads to better control of asthma.


Subject(s)
Asthma/complications , Gastroesophageal Reflux/complications , Adult , Asthma/physiopathology , Child , Gastroesophageal Reflux/diagnosis , Gastroesophageal Reflux/physiopathology , Gastroesophageal Reflux/therapy , Humans
16.
JAMA ; 279(11): 835-6; author reply 836, 1998 Mar 18.
Article in English | MEDLINE | ID: mdl-9515992

Subject(s)
Philosophy, Medical
18.
JAMA ; 277(12): 962-3, 1997 Mar 26.
Article in English | MEDLINE | ID: mdl-9091663
19.
JAMA ; 274(20): 1588, 1995.
Article in English | MEDLINE | ID: mdl-7474241
20.
Am J Med Genet ; 59(2): 161-3, 1995 Nov 06.
Article in English | MEDLINE | ID: mdl-8588579

ABSTRACT

Multiple abnormalities were observed in a newborn infant with a deletion in the long arm of chromosome 21, from band 22q22.1-->qter. The phenotype of this infant was similar to that previously described in infants with deletions spanning the long arm of chromosome 21, from the centromere to 21q22 [Rethoré et al., 1972, Exp Cell Res 70:455-456, 1973, Ann Genet (Paris) 16:271-275]. However, as a phenotypically normal child with normal intelligence and with deletion of 21q11.1-21q21.3 has also been identified [Korenberg et al., 1991, Hum Genet 87:112-118], this case suggests that the critical region of deletion for the 21q- phenotype lies distal to 21q21, within 21q22.1-22.2.


Subject(s)
Abnormalities, Multiple/genetics , Chromosome Deletion , Chromosomes, Human, Pair 21/genetics , Chromosomes, Human, Pair 21/ultrastructure , Face/abnormalities , Female , Heart Defects, Congenital/genetics , Humans , Infant, Newborn , Phenotype , Translocation, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...